Free Trial

BioCardia (BCDA) Short Interest Ratio & Short Volume

BioCardia logo
$2.26 +0.12 (+5.61%)
(As of 11/22/2024 ET)

BioCardia Short Interest Data

BioCardia (BCDA) has a short interest of 86,300 shares, representing 3.17% of the float (the number of shares available for trading by the public). This marks a 72.60% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 60,268 shares to cover all short positions.

Current Short Interest
86,300 shares
Previous Short Interest
50,000 shares
Change Vs. Previous Month
+72.60%
Dollar Volume Sold Short
$201,079.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
4,584,000 shares
Float Size
2,720,000 shares
Short Percent of Float
3.17%
Today's Trading Volume
30,704 shares
Average Trading Volume
60,268 shares
Today's Volume Vs. Average
51%
Short Selling BioCardia?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for BioCardia and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BCDA Short Interest Over Time

BCDA Days to Cover Over Time

BCDA Percentage of Float Shorted Over Time

BioCardia Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202486,300 shares $201,079.00 +72.6%3.2%0.1 $2.33
10/15/202450,000 shares $122,000.00 -62.2%1.8%0.1 $2.44
9/30/2024132,100 shares $412,152.00 -12.6%4.8%0.2 $3.12
9/15/2024151,200 shares $449,064.00 -91.7%6.4%0.2 $2.97
8/31/20241,830,000 shares $5.58 million +2,719.7%84.3%2.3 $3.05
8/15/202464,900 shares $188,210.00 +104.1%4.3%0.4 $2.90
7/31/202431,800 shares $95,718.00 +8.2%2.5%0.2 $3.01
7/15/202429,400 shares $104,076.00 -38.8%2.3%0.2 $3.54
6/30/202448,000 shares $142,560.00 -37.7%3.7%0.4 $2.97
6/15/202477,100 shares $262,911.00 +267.1%6.0%0.6 $3.41
5/31/202421,000 shares $97,020.00 -91.1%1.6%0.2 $4.62
5/15/2024235,400 shares $92,041.40 -10.4%N/A0.7 $0.39
4/30/2024262,800 shares $101,729.88 -3.1%N/A0.8 $0.39
4/15/2024271,200 shares $100,994.88 -49.4%N/A0.8 $0.37
3/31/2024535,900 shares $218,111.30 -46.9%N/A1.4 $0.41
3/15/20241,010,000 shares $393,900.00 +927.5%6.2%2.7 $0.39
2/29/202498,300 shares $54,065.00 -67.0%0.7%0.3 $0.55
2/15/2024297,600 shares $127,968.00 +84.2%2.5%1 $0.43
1/31/2024161,600 shares $73,237.12 +22.8%1.3%0.1 $0.45
1/15/2024131,600 shares $85,329.44 -39.2%1.1%0 $0.65
12/31/2023216,600 shares $143,865.72 -31.8%1.8%0.1 $0.66
12/15/2023317,800 shares $190,997.80 -9.0%2.7%0.1 $0.60
11/30/2023349,100 shares $216,860.92 +132.0%3.5%0.1 $0.62
11/15/2023150,500 shares $142,222.50 +13.4%1.5%0.1 $0.95
10/31/2023132,700 shares $49,404.21 -35.2%1.3%1.2 $0.37
10/15/2023204,900 shares $90,156.00 +9.8%2.1%1.5 $0.44
9/30/2023186,600 shares $80,219.34 +48.1%1.6%1.4 $0.43
9/15/2023126,000 shares $49,770.00 -36.7%1.1%0.9 $0.40
8/31/2023199,000 shares $155,220.00 +8.0%1.7%1.8 $0.78
8/15/2023184,300 shares $162,147.14 +575.1%1.5%1.9 $0.88
7/31/202327,300 shares $28,119.00 -84.0%0.2%0.3 $1.03
7/15/2023171,000 shares $398,430.00 -14.2%1.4%2.4 $2.33
6/30/2023199,400 shares $532,398.00 -4.3%1.6%5.1 $2.67
6/15/2023208,300 shares $477,007.00 +3.8%1.6%5.6 $2.29
5/31/2023200,600 shares $355,062.00 +1,443.1%1.6%6.9 $1.77
5/15/202313,000 shares $24,050.00 -29.4%0.1%0.5 $1.85
4/30/202318,400 shares $37,904.00 -12.0%0.1%0.9 $2.06
4/15/202320,900 shares $40,964.00 -23.7%0.1%0.9 $1.96
3/31/202327,400 shares $53,430.00 -26.9%0.2%1 $1.95
3/15/202337,500 shares $73,875.00 +4.8%0.3%1.2 $1.97
9 hidden AI stocks set to thrive in Trump’s new era (Ad)

AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)

Get the Name of These AI Picks Now
2/28/202335,800 shares $78,760.00 +96.7%0.3%0.7 $2.20
2/15/202318,200 shares $40,586.00 -56.6%0.1%0.4 $2.23
1/31/202341,900 shares $106,426.00 -4.3%0.3%0.9 $2.54
1/15/202343,800 shares $100,302.00 -15.4%0.4%1 $2.29
12/30/202251,800 shares $108,262.00 -40.6%0.4%1.2 $2.09
12/15/202287,200 shares $149,112.00 +149.1%0.7%2 $1.71
11/30/202235,000 shares $64,750.00 +44.0%0.2%0.8 $1.85
11/15/202224,300 shares $45,684.00 -42.1%0.2%0.5 $1.88
10/31/202242,000 shares $81,900.00 -24.5%0.3%0.7 $1.95
10/15/202255,600 shares $116,204.00 -37.3%0.4%0.9 $2.09
9/30/202288,600 shares $171,884.00 -7.2%0.7%1.4 $1.94
9/15/202295,500 shares $193,865.00 -2.7%0.7%1.6 $2.03
8/31/202298,100 shares $195,219.00 +182.7%0.7%1.4 $1.99
8/15/202234,700 shares $58,296.00 -42.1%0.3%0.7 $1.68
7/31/202259,900 shares $86,855.00 -25.7%0.5%1.2 $1.45
7/15/202280,600 shares $124,930.00 -47.7%0.8%1.2 $1.55
6/30/2022154,200 shares $223,590.00 -29.3%1.6%0.2 $1.45
6/15/2022218,100 shares $307,521.00 -42.2%2.3%0.3 $1.41
5/31/2022377,300 shares $633,864.00 -2.8%2.9%0.6 $1.68
5/15/2022388,200 shares $543,480.00 -38.1%3.0%0.6 $1.40
4/30/2022627,000 shares $965,580.00 -49.8%5.0%0.7 $1.54
4/15/20221,250,000 shares $1.86 million +150.1%10.0%0.7 $1.49
3/31/2022499,900 shares $1.03 million -5.7%4.0%0.4 $2.07
3/15/2022530,100 shares $1.03 million -10.4%4.2%0.4 $1.95
2/28/2022591,700 shares $1.22 million -45.2%4.7%0.4 $2.07
2/15/20221,080,000 shares $2.39 million +425.3%8.5%0.8 $2.21
1/31/2022205,600 shares $380,360.00 -7.3%1.6%0.2 $1.85
1/15/2022221,700 shares $390,192.00 -13.8%1.7%1.5 $1.76
12/31/2021257,300 shares $499,162.00 +57.5%2.0%1.8 $1.94
12/15/2021163,400 shares $281,048.00 -30.9%1.3%1.2 $1.72
11/30/2021236,300 shares $484,415.00 -10.0%1.9%1.7 $2.05
11/15/2021262,600 shares $643,370.00 -10.5%2.1%1.9 $2.45
10/29/2021293,300 shares $821,240.00 +3.8%2.3%2.1 $2.80
10/15/2021282,700 shares $828,311.00 +8.7%2.2%2 $2.93
9/30/2021260,000 shares $816,400.00 +33.2%2.0%1.8 $3.14
9/15/2021195,200 shares $554,368.00 -0.9%1.5%1.4 $2.84
8/31/2021197,000 shares $581,150.00 -34.0%1.6%2.8 $2.95
8/13/2021298,300 shares $924,730.00 +5.3%2.3%4 $3.10
7/30/2021283,400 shares $940,888.00 -13.8%2.2%3.8 $3.32
7/15/2021328,900 shares $1.11 million -10.7%2.6%4.2 $3.36
6/30/2021368,200 shares $1.46 million +2.1%2.9%4.2 $3.97
6/15/2021360,500 shares $1.60 million -20.0%2.8%3.4 $4.43
5/28/2021450,400 shares $1.84 million +4.9%3.6%4.3 $4.09
5/14/2021429,300 shares $1.43 million +2.0%N/A3.6 $3.32
4/30/2021420,900 shares $1.49 million -0.2%N/A2.6 $3.54
4/15/2021421,900 shares $1.73 million -7.9%N/A1.8 $4.09
3/31/2021458,300 shares $1.82 million +68.4%N/A1.5 $3.98
3/15/2021272,200 shares $1.09 million +25.3%N/A0.5 $4.00
2/26/2021217,300 shares $873,546.00 +0.5%N/A0.1 $4.02
2/12/2021216,200 shares $1.08 million -63.5%N/A0.1 $4.98
9 hidden AI stocks set to thrive in Trump’s new era (Ad)

AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)

Get the Name of These AI Picks Now
1/29/2021591,600 shares $2.48 million -33.8%N/A0.2 $4.20
1/15/2021894,200 shares $3.35 million +49.8%N/A0.2 $3.75
12/31/2020597,100 shares $2.10 million +4,715.3%N/A0.2 $3.52
12/15/202012,400 shares $55,552.00 +9.7%N/A0 $4.48
11/30/202011,300 shares $26,555.00 -6.6%N/A0.2 $2.35
11/15/202012,100 shares $26,257.00 -57.4%N/A0.2 $2.17
10/30/202028,400 shares $58,220.00 +3.7%N/A0.3 $2.05
10/15/202027,400 shares $64,664.00 -9.9%N/A0.3 $2.36
9/30/202030,400 shares $69,008.00 +237.8%N/A0.3 $2.27
9/15/20209,000 shares $21,375.00 -61.9%N/A0 $2.38

BCDA Short Interest - Frequently Asked Questions

What is BioCardia's current short interest?

Short interest is the volume of BioCardia shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 86,300 shares of BCDA short. 3.17% of BioCardia's shares are currently sold short. Learn More on BioCardia's current short interest.

What is a good short interest percentage for BioCardia?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.17% of BioCardia's floating shares are currently sold short.

Is BioCardia's short interest increasing or decreasing?

BioCardia saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 86,300 shares, an increase of 72.6% from the previous total of 50,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is BioCardia's float size?

BioCardia currently has issued a total of 4,584,000 shares. Some of BioCardia's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioCardia currently has a public float of 2,720,000 shares.

How does BioCardia's short interest compare to its competitors?

3.17% of BioCardia's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioCardia: Cognition Therapeutics, Inc. (2.41%), Bullfrog AI Holdings, Inc. (4.76%), Flora Growth Corp. (9.66%), Marinus Pharmaceuticals, Inc. (10.26%), Cara Therapeutics, Inc. (2.06%), Tenax Therapeutics, Inc. (3.55%), Synlogic, Inc. (0.76%), Mannatech, Incorporated (0.19%), Aprea Therapeutics, Inc. (0.61%), Minerva Neurosciences, Inc. (0.13%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short BioCardia stock?

Short selling BCDA is an investing strategy that aims to generate trading profit from BioCardia as its price is falling. BCDA shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioCardia?

A short squeeze for BioCardia occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCDA, which in turn drives the price of the stock up even further.

How often is BioCardia's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCDA, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:BCDA) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners